Literature DB >> 18558432

Granulibacter bethesdensis isolated in a child patient with chronic granulomatous disease.

F C Rodríguez López1, F Franco-Alvarez de Luna, M C Gamero Delgado, I Ibarra de la Rosa, S Valdezate, J A Saez Nieto, M Casal.   

Abstract

Chronic granulomatous disease was diagnosed in a 10-year-old boy who, after some weeks' decline, developed acute respiratory distress leading to multiple organ failure and death. All microbiological analyses were negative, except two blood cultures from which the novel bacterium Granulibacter bethesdensis was isolated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558432     DOI: 10.1016/j.jinf.2008.04.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

Review 1.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

2.  Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.

Authors:  Jessica Chu; Helen H Song; Kol A Zarember; Teresa A Mills; John I Gallin
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

3.  Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.

Authors:  Kol A Zarember; Kimberly R Marshall-Batty; Anna R Cruz; Jessica Chu; Michael E Fenster; Adam R Shoffner; Larissa S Rogge; Adeline R Whitney; Meggan Czapiga; Helen H Song; Pamela A Shaw; Kunio Nagashima; Harry L Malech; Frank R DeLeo; Steven M Holland; John I Gallin; David E Greenberg
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

4.  Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease.

Authors:  Erick F Mayer; Philip Gialanella; Iona Munjal; Charlotte Cunningham-Rundles; Jasmeen Dara
Journal:  Pediatr Infect Dis J       Date:  2017-12       Impact factor: 2.129

5.  Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.

Authors:  Jessica Chu; Margery G Smelkinson; David W Dorward; Kol A Zarember; John I Gallin
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

6.  Serologic reactivity to the emerging pathogen Granulibacter bethesdensis.

Authors:  David E Greenberg; Adam R Shoffner; Kimberly R Marshall-Batty; Kriti Arora; Ming Zhao; Raynaldo Martin; Li Ding; Carl H Hammer; Pamela A Shaw; Douglas B Kuhns; Harry L Malech; John I Gallin; Kol A Zarember; Steven M Holland
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

7.  Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteria.

Authors:  Corentine Alauzet; Corinne Teyssier; Estelle Jumas-Bilak; Anne Gouby; Raphael Chiron; Christian Rabaud; François Counil; Alain Lozniewski; Hélène Marchandin
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

8.  Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.

Authors:  David E Greenberg; Daniel E Sturdevant; Kimberly R Marshall-Batty; Jessica Chu; Anthony M Pettinato; Kimmo Virtaneva; John Lane; Bruce L Geller; Stephen F Porcella; John I Gallin; Steven M Holland; Kol A Zarember
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.

Authors:  David E Greenberg; Adam R Shoffner; Adrian M Zelazny; Michael E Fenster; Kol A Zarember; Frida Stock; Li Ding; Kimberly R Marshall-Batty; Richard L Wasserman; David F Welch; Kishore Kanakabandi; Dan E Sturdevant; Kimmo Virtaneva; Stephen F Porcella; Patrick R Murray; Harry L Malech; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

10.  Methylotroph Infections and Chronic Granulomatous Disease.

Authors:  E Liana Falcone; Jennifer R Petts; Mary Beth Fasano; Bradley Ford; William M Nauseef; João Farela Neves; Maria João Simões; Millard L Tierce; M Teresa de la Morena; David E Greenberg; Christa S Zerbe; Adrian M Zelazny; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.